JOHNSON CONTR.INTL.DL-,01/ IE00BY7QL619 /
15.05.2024 08:20:01 | Diff. -0,6400 | Volumen | Geld12:54:21 | Brief12:54:21 | Marktkapitalisierung | Dividendenr. | KGV |
---|---|---|---|---|---|---|---|
61,3600EUR | -1,03% | 0 Umsatz: 0.0000 |
61,3300Geld Vol: 100 | 62,2500Brief Vol: 100 | 41,64 Mrd.EUR | - | - |
GlobeNewswire
13:03
Unicycive Therapeutics Presents Bioequivalence Data on Oxylanthanum Carbonate (OLC) at the National ...
GlobeNewswire
13:01
Olema Oncology Announces Promising New Data for Palazestrant in Combination with Ribociclib Presente...
GlobeNewswire
13:00
BiomX to Host First Quarter 2024 Financial Results Conference Call and Webcast on May 21, 2024
GlobeNewswire
13:00
Edible Garden Reports Significant 27.6% Year-Over-Year Revenue Growth for First Quarter of 2024
GlobeNewswire
13:00
Dorman Products expands its catalog of cost-saving and aftermarket-exclusive repair solutions
GlobeNewswire
13:00
Plug to Revolutionize Middle-Mile Delivery with Class 6 Fuel Cell Electric Truck Integration
GlobeNewswire
13:00
Cabaletta Bio Reports First Quarter 2024 Financial Results and Provides Business Update
GlobeNewswire
13:00
Perspective Therapeutics Provides Recent Business Highlights and Reports Fiscal Q1 2024 Results
GlobeNewswire
13:00
Boralex announces a substantial 62% increase in net earnings and continued disciplined development o...
GlobeNewswire
13:00
T2 Biosystems Announces $8 Million Private Placement Priced At-The-Market Under Nasdaq Rules
GlobeNewswire
13:00
TFF Pharmaceuticals Provides Update on Tacrolimus Inhalation Powder (TFF TAC) Phase 2 Trial for the ...
GlobeNewswire
13:00
Creative Realities Inc. plans its expansion into EMEA and announces its beta launch to EMEA Integrat...
- Erste Seite
- Zurück
- 1
- 2
- 3
- 4
- Weiter
- Letzte Seite